UnitedHealth Group faces structural headwinds, political risks, and a sluggish recovery despite being undervalued. Learn more ...

Wedgewood Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter ...

L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) second quarter 2025 ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

UnitedHealth stock has plunged over 40% in 2025 and is approaching a key buy zone ahead of the Q2 2025 earnings.

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

UnitedHealth Group (UNH) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.01%. Meanwhile ...

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across ...

UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about ...

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

According to a recent SEC filing, Ayrshire Capital Management LLC fully liquidated its holding in UnitedHealth Group. The ...

UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and revenue, and dominates the healthcare industry through its UnitedHealthcare insurance arm and Optum health services.